301 related articles for article (PubMed ID: 27933586)
21. Studies on paclitaxel-loaded glyceryl monostearate nanoparticles.
Shenoy VS; Rajyaguru TH; Gude RP; Murthy RS
J Microencapsul; 2009 Sep; 26(6):471-8. PubMed ID: 19169921
[TBL] [Abstract][Full Text] [Related]
22. Part I: Development and optimization of solid-lipid nanoparticles using Box-Behnken statistical design for ocular delivery of gatifloxacin.
Abul Kalam M; Sultana Y; Ali A; Aqil M; Mishra AK; Aljuffali IA; Alshamsan A
J Biomed Mater Res A; 2013 Jun; 101(6):1813-27. PubMed ID: 23255511
[TBL] [Abstract][Full Text] [Related]
23. Effect of lipid matrix on repaglinide-loaded solid lipid nanoparticles for oral delivery.
Rawat MK; Jain A; Mishra A; Muthu MS; Singh S
Ther Deliv; 2010 Jul; 1(1):63-73. PubMed ID: 22816120
[TBL] [Abstract][Full Text] [Related]
24. Physicochemical characterization of solid lipid nanoparticles (SLNs) prepared by a novel microemulsion technique.
Shah RM; Malherbe F; Eldridge D; Palombo EA; Harding IH
J Colloid Interface Sci; 2014 Aug; 428():286-94. PubMed ID: 24910064
[TBL] [Abstract][Full Text] [Related]
25. Development of Perphenazine-Loaded Solid Lipid Nanoparticles: Statistical Optimization and Cytotoxicity Studies.
Farsani PA; Mahjub R; Mohammadi M; Oliaei SS; Mahboobian MM
Biomed Res Int; 2021; 2021():6619195. PubMed ID: 33997026
[TBL] [Abstract][Full Text] [Related]
26. Bixin loaded solid lipid nanoparticles for enhanced hepatoprotection--preparation, characterisation and in vivo evaluation.
Rao MP; Manjunath K; Bhagawati ST; Thippeswamy BS
Int J Pharm; 2014 Oct; 473(1-2):485-92. PubMed ID: 25066077
[TBL] [Abstract][Full Text] [Related]
27. Characterization and formulation optimization of solid lipid nanoparticles in vitamin K1 delivery.
Liu CH; Wu CT; Fang JY
Drug Dev Ind Pharm; 2010 Jul; 36(7):751-61. PubMed ID: 20136495
[TBL] [Abstract][Full Text] [Related]
28. Preparation, characterization and in vitro cytotoxicity of Fenofibrate and Nabumetone loaded solid lipid nanoparticles.
Kumar R; Singh A; Sharma K; Dhasmana D; Garg N; Siril PF
Mater Sci Eng C Mater Biol Appl; 2020 Jan; 106():110184. PubMed ID: 31753394
[TBL] [Abstract][Full Text] [Related]
29. Drug-Lipid-Surfactant Miscibility for the Development of Solid Lipid Nanoparticles.
Trivino A; Gumireddy A; Chauhan H
AAPS PharmSciTech; 2019 Jan; 20(2):46. PubMed ID: 30617602
[TBL] [Abstract][Full Text] [Related]
30. Cyclosporine a loaded solid lipid nanoparticles: optimization of formulation, process variable and characterization.
Varia JK; Dodiya SS; Sawant KK
Curr Drug Deliv; 2008 Jan; 5(1):64-9. PubMed ID: 18220553
[TBL] [Abstract][Full Text] [Related]
31. A novel monolithic controlled delivery system of resveratrol for enhanced hepatoprotection: nanoformulation development, pharmacokinetics and pharmacodynamics.
Singh A; Ahmad I; Ahmad S; Iqbal Z; Ahmad FJ
Drug Dev Ind Pharm; 2016 Sep; 42(9):1524-36. PubMed ID: 26902951
[TBL] [Abstract][Full Text] [Related]
32. Development of Domperidone Solid Lipid Nanoparticles: In Vitro and In Vivo Characterization.
Shazly GA; Alshehri S; Ibrahim MA; Tawfeek HM; Razik JA; Hassan YA; Shakeel F
AAPS PharmSciTech; 2018 May; 19(4):1712-1719. PubMed ID: 29532427
[TBL] [Abstract][Full Text] [Related]
33. The effective encapsulation of a hydrophobic lipid-insoluble drug in solid lipid nanoparticles using a modified double emulsion solvent evaporation method.
Nabi-Meibodi M; Vatanara A; Najafabadi AR; Rouini MR; Ramezani V; Gilani K; Etemadzadeh SM; Azadmanesh K
Colloids Surf B Biointerfaces; 2013 Dec; 112():408-14. PubMed ID: 24036624
[TBL] [Abstract][Full Text] [Related]
34. Benzocaine loaded solid lipid nanoparticles: Formulation design, in vitro and in vivo evaluation of local anesthetic effect.
Basha M; Abd El-Alim SH; Kassem AA; El Awdan S; Awad G
Curr Drug Deliv; 2015; 12(6):680-92. PubMed ID: 26138680
[TBL] [Abstract][Full Text] [Related]
35. The design of naproxen solid lipid nanoparticles to target skin layers.
Akbari J; Saeedi M; Morteza-Semnani K; Rostamkalaei SS; Asadi M; Asare-Addo K; Nokhodchi A
Colloids Surf B Biointerfaces; 2016 Sep; 145():626-633. PubMed ID: 27288817
[TBL] [Abstract][Full Text] [Related]
36. Preparation, characterization, and optimization of auraptene-loaded solid lipid nanoparticles as a natural anti-inflammatory agent: In vivo and in vitro evaluations.
Daneshmand S; Jaafari MR; Movaffagh J; Malaekeh-Nikouei B; Iranshahi M; Seyedian Moghaddam A; Tayarani Najaran Z; Golmohammadzadeh S
Colloids Surf B Biointerfaces; 2018 Apr; 164():332-339. PubMed ID: 29413613
[TBL] [Abstract][Full Text] [Related]
37. Preparation and characterization of solid lipid nanoparticles loaded with frankincense and myrrh oil.
Shi F; Zhao JH; Liu Y; Wang Z; Zhang YT; Feng NP
Int J Nanomedicine; 2012; 7():2033-43. PubMed ID: 22619540
[TBL] [Abstract][Full Text] [Related]
38. Lipid nanoparticles of zaleplon for improved oral delivery by Box-Behnken design: optimization, in vitro and in vivo evaluation.
Dudhipala N; Janga KY
Drug Dev Ind Pharm; 2017 Jul; 43(7):1205-1214. PubMed ID: 28274147
[TBL] [Abstract][Full Text] [Related]
39. Development of transmucosal patch loaded with anesthetic and analgesic for dental procedures and in vivo evaluation.
Nidhi M; Patro MN; Kusumvalli S; Kusumdevi V
Int J Nanomedicine; 2016; 11():2901-20. PubMed ID: 27382279
[TBL] [Abstract][Full Text] [Related]
40. Preformulation, Characterization, and
Algul D; Duman G; Ozdemir S; Acar ET; Yener G
J Cosmet Sci; 2018; 69(3):165-173. PubMed ID: 30052191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
